apomorphine has been researched along with ubiquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyle, JT; Miyamoto, M | 1 |
| Choy, YB; Lee, SH; Lim, J; Paek, SH; Park, CG; Park, HR; Park, HW; Park, M | 1 |
2 other study(ies) available for apomorphine and ubiquinone
| Article | Year |
|---|---|
Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.
Topics: Animals; Apomorphine; Benzoquinones; Choline O-Acetyltransferase; Corpus Striatum; Glutamate Decarboxylase; Histocytochemistry; Kainic Acid; Kinetics; Male; Motor Activity; NADPH Dehydrogenase; Nerve Degeneration; Oxadiazoles; Pyridines; Quinolinic Acid; Quinolinic Acids; Quinones; Quisqualic Acid; Rats; Rats, Inbred Strains; Ubiquinone | 1990 |
Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
Topics: Administration, Oral; Animals; Apomorphine; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Drug; Down-Regulation; Inflammation; Infusion Pumps, Implantable; Infusions, Parenteral; Male; Neovascularization, Physiologic; Neurogenesis; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Ubiquinone | 2020 |